We use strictly necessary cookies to make our site work. We would also like to set optional cookies (analytical, functional and YouTube) to enhance and improve our service. You can opt-out of these cookies. By clicking “Accept All Cookies” you can agree to the use of all cookies.

Cookies Statement and Privacy Statement

The HSE National Cancer Control Programme (NCCP) welcomes the allocation of €32m in Budget 2021

HSE Press Release: Wednesday, 14 October 2020

Of this funding, €20m will expedite the implementation of the National Cancer Strategy (2017 -2026), in collaboration with the Department of Health.  A further €12m has also been allocated – in addition to the €2.3m already secured in the HSE Winter Plan – to fund the continuance of cancer services in the Covid environment.  This will have a significant impact on the quality and timeliness of cancer care for all patients in Ireland.

Key areas of focus in 2021 include improved access to standard of care cancer diagnostics, the expansion of treatment options for cancer patients and the development of our cancer genetics service. Surgical centralisation to improve the outcomes for cancer patients is also a priority.

Cancer prevention is an important focus for NCCP, as up to 40% of cancers are potentially preventable.  NCCP will fund cancer prevention initiatives to help reduce the cancer burden, aligning this with the Healthy Ireland initiatives.

In line with the National Cancer Strategy, psycho-oncology services and improved quality of life for those living with and beyond cancer will be prioritised, with enhanced supports made available to cancer patients and their families.

Prof Risteárd Ó Laoide, Director, HSE National Cancer Control Programme said, “Our cancer diagnostic and treatment services have continued throughout the pandemic.  However, the last few months have been difficult for cancer patients and for the public. The funding provided will help to get us back on an even keel, and, with the further Strategy funding, enable us to drive on with improvements across the cancer patient experience.”   

Cancer is the second most common cause of death after disease of the circulation such as heart disease and strokes. Over 8,000 deaths from cancer are reported every year.  Cancer control aims to prevent cancer, treat cancer, and increase survival and quality of life for those who develop cancer, by converting the knowledge gained through research, surveillance and outcome evaluation into strategies and actions.

The NCCP was established in 2007 to ensure that all elements of this cancer policy and are delivered to the maximum possible extent. NCCP continues to reorganise cancer services to achieve better outcomes for patients and looks forward to progressing all aspects of the Cancer Strategy in 2021.

 

Ends

Last updated on: 14 / 10 / 2020